Speaking of insomnia: any general thoughts from any of the insomniacs on this board about the market potential for Ambion in a rapid-acting oral spray formulation?
Just looking around at various investment alternatives in the insomnia space. While it is true that getting them through the FDA might be challenging, I don't think this barrier is relevant for short- and intermediate term performance as an investment. Particularly given the enthusiasm that potential new treatment alternatives are met with.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.